AI could help doctors predict which gastric cancer patients benefit from Pre-Surgery treatment
NCT ID NCT07401199
First seen Feb 12, 2026 · Last updated May 08, 2026 · Updated 11 times
Summary
This study aims to develop an artificial intelligence (AI) system that can predict how well stomach cancer will respond to chemotherapy and immunotherapy given before surgery. Researchers will collect data from 2,000 patients with locally advanced gastric cancer and use their CT scans and tissue samples to train the AI. If successful, this tool could help doctors personalize treatment, ensuring patients get the most effective therapy while avoiding unnecessary side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER (GC) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.